Inhibition of EGFR-MEK signaling pathway leads to the downregulation of Bcl-2 and induced myeloid leukemia cell differentiation protein Mcl-1 (Mcl-1) and promotes apoptosis to confer sensitivity to anti-EGFR treatments [98]. Here, EGFR is linked to leukemia.